ActX, Inc.
Genetic risk assessment and actionable variant interpretation platform for clinical use
- Sector
- Medtech
- Headquarters
- SEATTLE, WA
- Founded
- 2012
- Latest Form D
- $6M, Dec 2022
- Total capital
- $10.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $10.9M
- 5 Form D · last Dec 2022
- 46 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 4 pending · first 2020
- Rank in peer group#29 of 73
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$6M
- Private capital raisedForm D · SEC · 4th filing$1.9M
- Private capital raisedForm D · SEC · 3rd filing$309K
- Private capital raisedForm D · SEC · 2nd filing$750K
- Private capital raisedForm D · SEC · 1st filing$1.9M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 73 peers
Line = medianMedtech · Platform
- Granted patents#29 · top 40%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Andrew UryExecutive Officer, DirectorNamed in SEC Form D filings
- Doug BevisDirectorNamed in SEC Form D filings
- Eric MichelmanDirectorNamed in SEC Form D filings
- John O?HalloranDirectorNamed in SEC Form D filings
- Sarah CorleyDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 5- PendingCloud-like Medical-information ServiceUSPTOApplication 16776858
- GrantedCloud-like Medical-information ServiceUSPTOUS 10,586,612
- PendingCloud-like Medical-information ServiceUSPTOApplication PCTUS2014020000
Show all 5 patent records
- Cloud-like Medical-information ServiceJun 4, 2020 · Application 16776858Pending
- Cloud-like Medical-information ServiceMar 10, 2020 · US 10,586,612Granted
- Cloud-like Medical-information ServiceApplication PCTUS2014020000Pending
- Cell Therapy For Limiting Overzealous Inflammatory Reactions In Tissue HealingApplication PCTUS2012025814Pending
- Recovery Of Tissue Function Following Administration Of B Cells To Injured TissueApplication PCTUS2006014445Pending
Related companies, and why
- NOVIAN HEALTH INC.Similar federal contract value in Medtech · null in contracts
- VistaPath Biosystems, Inc.Similar federal contract value in Medtech · null in contracts
- Koya Medical, Inc.Similar federal contract value in Medtech · null in contracts
- Sylke, Inc.Similar federal contract value in Medtech · null in contracts
- Ocudyne, Inc.Similar federal contract value in Medtech · null in contracts
- Zebrafish Labs Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .